In ALS patients, EPHA4 expression levels correlate inversely with disease onset and survival, whereas loss-of-function EPHA4 variants are linked to longer survival (Van Hoecke et al., 2012). Here, EPHA4 is linked to amyotrophic lateral sclerosis.